Journal Article

PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing

IEEE Security and Privacy (2022) 20(6) 53-65
DOI: 10.1109/MSEC.2022.3160465
0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Biopharmaceutical production systems and processes are vulnerable to cyberattacks from sophisticated adversaries. Therefore, it is imperative to start building biopharmaceutical manufacturing systems that offer verifiable formalism and transform the current state of security across all production stages.

Cite

CITATION STYLE

APA

Grimes, H. D., Ciocarlie, G. F., Yu, B., Wijesekera, D., Shannon, G., Austad, W., … Reid, B. (2022). PURE Biomanufacturing: Secure, Pandemic-Adaptive Biomanufacturing. IEEE Security and Privacy, 20(6), 53–65. https://doi.org/10.1109/MSEC.2022.3160465

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free